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Abstract
Background: Affective temperaments (anxious, depressive, cyclothymic, irritable and hyperthymic) measure
subclinical manifestations of major mood disorders. Furthermore, cumulating evidence suggests their involvement
in somatic disorders as well. We aimed to assess associations between affective temperament scores and blood
pressure and arterial stiffness parameters in hypertensive patients.
Methods: In this cross-sectional study, 173 patients with well-controlled or grade 1 chronic hypertension, with
no history of depression, completed the TEMPS-A, Beck Depression Inventory (BDI) and Hamilton Anxiety
Scale (HAM-A) questionnaires in three GP practices. Arterial stiffness was measured with tonometry (PulsePen).
Results: According to multiple linear regression analysis, cyclothymic temperament score was positively
associated with brachial systolic blood pressure independently of age, sex, total cholesterol, brachial diastolic
blood pressure, BDI, HAM-A and the use of alprazolam (β = 0.529, p = 0.042), while hyperthymic temperament
score was negatively related to augmentation index independent of age, sex, smoking, heart rate, BDI, HAM-A
and the use of alprazolam (β = -0.612, p = 0.013). A significant interaction was found between cyclothymic
temperament score and sex in predicting brachial systolic blood pressure (p = 0.025), between irritable and
anxious temperament scores and sex in predicting pulse wave velocity (p = 0.021, p = 0.023, respectively) and
an interaction with borderline significance between hyperthymic temperament score and sex in predicting
augmentation index (p = 0.052).
Conclusions: The present findings highlight elevated blood pressure among subjects with high cyclothymic
temperament as well as an increased level of arterial stiffening in subjects with low hyperthymic scores suggesting that
affective temperaments may play a role in the development of hypertension and arterial stiffening and may thus
represent markers of cardiovascular risk. Sex differences were also present in these associations.
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Background
Cardiovascular diseases are the leading cause of morbidity
and mortality in most industrialized countries worldwide,
despite highly effective preventive treatments. A continu-
ous linear relationship between elevated blood pressure
and incident cardiovascular events is well known at all
ages and in all ethnic groups [1–5]. In addition to elevated
blood pressure, arterial stiffening – integrating the damage
of risk factors on the aortic wall over a long period [6] – is
increasingly recognized as a marker and mediator of car-
diovascular diseases. Accordingly, carotid-femoral pulse
wave velocity (PWV), an accepted non-invasive measure
of arterial stiffness, is recommended for cardiovascular
risk prediction among hypertensive patients in European
Guidelines [7].
Depression is also a common public health problem in
the Western world and its strong connection with cardio-
vascular diseases is broadly recognized [8]. The pathophys-
iologies of depression and cardiovascular diseases show
several similarities that include the dysregulation of meta-
bolic, immune-inflammatory and autonomic systems as
well as the hypothalamic-pituitary axis [9]. In addition to
depression, anger, hostility and anxiety – the negative
impact of adverse individual psychological traits and char-
acteristics – are also well-documented risk factors of cor-
onary heart diseases [10, 11], while antagonism-related
traits also appear to predict a variety of cardiovascular out-
comes [12, 13].
Temperament is regarded as an inherited part of
personality and represents the biologically stable core
of emotional reactivity [14, 15]; however, there is on-
going discussion regarding the influence of age on de-
pressive temperament with differences between man
and women also being present [16]. Affective tempera-
ments can be measured on five temperament scales by
the Temperament Evaluation of Memphis, Pisa, Paris
and San Diego Autoquestionnaire (TEMPS-A) [17].
Hyperthymic temperament is characterized by upbeat,
overconfident and over-energetic traits while depressive
temperament is self-denying, striving to live in harmony
with others and sensitive to suffering. Anxious tempera-
ment can best be explained by exaggerated worries espe-
cially toward family members. Cyclothymic temperament
shows affective instability with rapid mood shifts and in-
tense emotions, while irritable temperament incorporates
skeptical and critical traits [15, 18, 19]. Affective tempera-
ments are also associated with numerous other measures
of psychopathology [20]. Specific affective temperament
types are the subclinical, trait-related manifestations and
commonly the antecedents of minor and major mood dis-
orders [21], where hyperthymic affective temperament can
inversely be related to depression [22]. Recently, we de-
scribed an association between chronic hypertension and
the dominant cyclothymic temperament [23]. Cyclothymic
temperament was also associated with acute coronary
events in hypertensive patients [24]. In a small matched
case-control study comparing hypertensive patients with
and without dominant affective temperaments, we found
lower peripheral and central diastolic blood pressure
values and decreased serum brain-derived neurotrophic
factor levels in patients with dominant temperaments
[25]. Since the ratio of those subjects who score high on
different temperament directions while having a dominant
affective temperament is relatively low (rarely does a sub-
ject have multiple dominant temperaments), as found in
only 16.8 % of the general population [26], it would be
important to ascertain the continuous association between
affective temperament scores and blood pressure or
arterial stiffness parameters.
We hypothesized that individual affective tempera-
ment scores may be related to brachial blood pressure as
well as arterial stiffness in chronic hypertensive patients.
We speculated a positive association in instances of de-
pressive, cyclothymic, irritable or anxious temperaments
and an inverse association in instances of hyperthymic
temperament. We also hypothesized the presence of sex
differences in relation to these studied associations.
Methods
Patients
In the present cross-sectional study, 173 Caucasian pa-
tients with well-controlled or grade 1 chronic (on medi-
cation for >3 months) hypertension were investigated
in three primary care practices. Patients with atrial
fibrillation and treated depression or with dementia
potentially interfering with the completion of question-
naires were excluded. Patients on moderate doses of
alprazolam (<0.5 mg/day) were not excluded. All of the
48 patients of our previous pilot study [25] were also
involved in the present study.
Evaluation of affective temperaments, depression and
anxiety
The Temperament Evaluation of Memphis, Pisa, Paris
and San Diego Autoquestionnaire (TEMPS-A) was used
to assess affective temperaments on depressive, cyclothy-
mic, hyperthymic, irritable and anxious subscales, re-
quiring ‘yes’ (score 1) or ‘no’ (score 0) answers [17].
TEMPS-A contains 110 items (109 in the version for
males) and the questions of the various temperament
types are grouped together as follows:
1. depressive temperament: questions 1 to 21
(21 points)
2. cyclothymic temperament: questions 22 to 42
(21 points)
3. hyperthymic temperament: questions 23 to 63
(21 points)
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4. irritable temperament: questions 64 to 84
(21 points in women, 20 in the men’s version)
5. anxious temperament: questions 85 to 110
(26 points).
TEMPS-A has been extensively studied, translated into
more than 25 languages and validated in several of the
latter. Similarities and differences were also found in na-
tional samples which suggest that distribution of
affective temperaments has both universal and cultural-
specific characteristics [16].
The Beck Depression Inventory (BDI), created by
Aaron T. Beck, is a 21-question multiple-choice self-
report questionnaire and is one of the widely used in-
struments for measuring depression severity. Partici-
pants are asked to make ratings on a four point scale,
where a higher score correlates with more severe depres-
sion [27].
The Hamilton Anxiety Scale (HAM-A) was used to
study the severity of anxiety. The scale consists of 14
items, each item is scored on a scale of 0 (not present)
to 4 (severe anxiety) [28].
Blood pressure and arterial stiffness measurements
Measurements were performed in a temperature-
controlled room, between 7.00 and 8.00 a.m. prior to
blood collection. Patients were required to fast overnight
and refrain from smoking and drinking caffeine-
containing beverages before the procedure, but to take
their usual blood pressure medication. Upon arrival and
after 5 min rest, two brachial blood pressure measure-
ments were taken on each arm in the sitting position
with a validated oscillometric blood pressure device
(Omron M3). The mean value of the higher side of arms
was further taken into calculation as brachial systolic
(SBPbrach) and diastolic (DBPbrach) blood pressures
and heart rate. Brachial pulse pressure (PPbrach) was
also calculated from these data. The subjects were next
fitted with arterial stiffness measurement device and
were asked to rest in the supine position for approxi-
mately 15 min before being measured. Arterial stiffness
parameters were evaluated with the gold-standard tono-
metric method (PulsePen, DiaTecne, Milan, Italy) [29].
This method provides estimates of pulse wave velocity
(PWV) and in which central systolic blood pressure
(SBPcentr), central pulse pressure (PPcentr) and pulse
pressure amplification (PPAmp) can be calculated. Aug-
mentation index (Aix), a widely used wave reflection
parameter, can also be measured by automatic identifica-
tion of the “first shoulder” (inflection point) of the aver-
aged carotid pulse signal by the PulsePen software. This
index is provided by the pressure amplitude following
this point divided by the pulse pressure and calculated
as a percentage. In these calculations, brachial blood
pressure values measured in the supine position were
used, which were required for calibration after each (ca-
rotid or femoral) pulse wave detection. In each subject,
two sequences of arterial stiffness measurements were
performed and their mean used for statistical analysis. In
the PWV calculations, 80 % of the carotid-femoral dis-
tance was used, according the most recent recommenda-
tion [30]. The intra- and interobserver variability of
PWV measurements obtained by the PulsePen device in
hypertensive patients was 4.6 and 6.3 %, respectively.
Since PulsePen calculates pressures based on brachial
diastolic blood pressure calibration, the calculated cen-
tral diastolic blood pressure is identical to the brachial
diastolic blood pressure assessed in the supine position
[29].
Statistical analysis
Descriptive data are expressed as mean ± standard devi-
ation or median with interquartile ranges or percentages.
Normality of continuous parameters was tested with the
Kolmogorov-Smirnov test. Pearson correlation coeffi-
cients were calculated to study the relationship between
affective temperament scores and demographic,
hemodynamic or arterial stiffness parameters. Multiple
linear regression analysis was used to study the determi-
nants of these hemodynamic or arterial stiffness parame-
ters which were associated in univariate analysis with
affective temperaments. Based on literature data, sex dif-
ferences in the association between affective tempera-
ments and the studied hemodynamic or arterial stiffness
parameters [16] were expected, and therefore sex and its
interaction with the given affective parameter was in-
cluded into all regression models and where an inter-
action was found, such interaction was further studied.
A two-sided p < 0.05 was considered to be significant.
SPSS 13.0 for Windows was used for all calculations.
Results
A total of 173 subjects were included. Baseline demo-
graphic and laboratory parameters, current medication,
TEMPS-A, BDI and HAM-A scores, central blood pres-
sure and arterial stiffness parameters are summarized in
Table 1. The median number of antihypertensive drugs
taken was 2 (IQR: 2-3).
Table 2 lists the hemodynamic or arterial stiffness pa-
rameters and their significant correlations for which
affective temperaments were also significantly associated.
Table 2 also shows those variables which were not sig-
nificantly correlated with outcome variables, but were
entered into the final multiple regression models. Partial
correlations corrected for age and sex are also demon-
strated. Although, in univariate models, affective tem-
perament scores were associated with hemodynamic or
arterial stiffness parameters in many cases, however,
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upon further correction for age and sex, certain temper-
aments failed to be independent covariables of these
parameters, notably irritable temperament score of bra-
chial systolic blood pressure (p = 0.056) and depressive
temperament score of Aix (p = 0.595). Table 3 demon-
strates that cyclothymic temperament score was an inde-
pendent covariate of brachial systolic blood pressure and
hyperthymic temperament of Aix after adjustment for
further relevant confounders. In the final model adjusted
for all potential confounders, a one-unit increase in cyclo-
thymic score was associated with 0.529 (95 % CI: 0.019-
1.040) mmHg higher brachial systolic blood pressure
while a one-unit increase in hyperthymic score was associ-
ated with -0.612 (95 % CI: -1.092–0.132) % lower Aix.
With regard to the association between PWV and irrit-
able temperament score, the correlation still remained sig-
nificant (p = 0.012) after adjustment for age, sex, brachial
systolic blood pressure, GFR-EPI, blood glucose and dur-
ation of hypertension, although became non-significant
after further adjustment for BDI and HAM-A scores and
the use of alprazolam (p = 0.078). The same results were
also found for anxious temperament score and PWV: the
significant association (p = 0.043) that was present after
adjustment for age, sex, brachial systolic blood pressure,
GFR-EPI, blood glucose and duration of hypertension
disappeared after further adjustment for BDI and HAM-A
scores and the use of alprazolam (p = 0.475).
When studying the interaction between cyclothymic tem-
perament score and sex in predicting brachial systolic blood
pressure, a significant association was found (p = 0.025,
Fig. 1a). There was a positive association between cyclothy-
mic temperament score and brachial systolic blood pres-
sure in men (B = 1.012, SE = 0.392, p = 0.011) which was
absent in women (B = 0.294, SE = 0.311, p = 0.346). After
adjustment for age, brachial diastolic blood pressure, chol-
esterol and triglycerides, this interaction became non-
significant (p = 0.090; in men B = 0.680, SE = 0.347, p =
0.052 and in women B = 0.279, SE = 0.272, p = 0.307).
Table 1 Baseline characteristics of study participants
N (male/female) 173 (68/105)
Age (years) 63 (53-70)
Duration of hypertension (year) 9 (3-16)
Diabetes [n (%)] 38 (22)
CV disease [n (%)] 26 (15)
Current smoker [n (%)] 33 (19.1)
Body height [cm] 168 (160-174)
Body weight [kg] 80 (70-90)
BMI [kg/m2] 27.8 (25.3-31.2)
Blood glucose [mmol/l] 5.6 (5.1-6.6)
GFR-EPI [ml/min/1.73 m2] 81.9 (67.9-90)
Uric acid [μmol/l] 324.2 ± 79.6
Total cholesterol [mmol/l] 5.2 ± 1.1
Triglyceride [mmol/l] 1.4 (1.1-2.1)
Medications
ACE-inhibitor [n (%)] 116 (67.1)
ARB [n (%)] 35 (20.2)
Calcium channel
blocker [n (%)]
88 (50.9)
Beta-blocker [n (%)] 98 (56.6)
Diuretic [n (%)] 72 (41.6)
Antiplatelet drug [n (%)] 52 (30.1)
Statin [n (%)] 57 (33.4)
Alprazolam [n (%)] 23 (13.3)
TEMPS-A, BDI, HAM-A scores
Depressive 6 (4-9)
Cyclothymic 3 (1-5)
Hyperthymic 12 (9-14)
Irritable 3 (2-6)
Anxious 4 (2-9)
BDI 5 (2-9)
HAM-A 5 (2-10)
Hemodynamic. arterial stiffness
parameters
Heart rate [1/min] 70.8 (64.8-78)
SBPbrach [mmHg] 133.5 ± 12
DBPbrach [mmHg] 75.6 ± 9.2
PPbrach [mmHg] 54.2 (47.1-62.4)
SBPcentr [mmHg] 123 (113.2-130.8)
Table 1 Baseline characteristics of study participants (Continued)
PPcentr [mmHg] 51 (43.5-60.4)
PPAmp 1.07 (1.00-1.13)
PWV (m/sec) 8.7 (7.7-9.9)
Aix (%) 15.5 (8.5-25.2)
Data are presented as mean ± SD or median (interquartile range). Categorical
parameters are presented as n (%). CV diseases cardiovascular diseases, BMI
body mass index, GFR-EPI glomerular filtration rate assessed by the chronic
kidney disease epidemiology collaboration glomerular filtration rate equation,
ACE Angiotensin converting enzyme, ARB angiotensin II receptor blocker,
TEMPS-A Temperament Evaluation of Memphis Pisa, Paris and San Diego
questionnaire, BDI Beck Depression Inventory, HAM-A Hamilton Anxiety Scale,
SBPbrach brachial systolic pressure, DBPbrach brachial diastolic pressure,
PPbrach brachial pulse pressure, SBPcentr central systolic pressure, PPcentr
central pulse pressure, PPAmp pulse pressure amplification, PWV carotid-
femoral pulse wave velocity, Aix augmentation index
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There was also a significant interaction between irrit-
able temperament score and sex in predicting PWV (p =
0.021). There was a positive association between irritable
temperament score and PWV in men (B = 0.154, SE =
0.060, p = 0.012) which was absent in women (B = 0.076,
SE = 0.064, p = 0.235) (Fig. 1b). After adjustment for age,
blood glucose, brachial systolic blood pressure and GFR-
EPI, the interaction p-value was attenuated (p = 0.037),
however the strength of the association remained similar
(in men B = 0.104, SE = 0.050, p = 0.039 and in women B
= 0.082, SE = 0.052, p = 0.116). The interaction became
non-significant (p = 0.168) after further adjustment for
BDI and HAMA-A scores and the regular use of
alprazolam (in men B = 0.091, SE = 0.051, p = 0.078 and
in women B = 0.054, SE = 0.061, p = 0.375).
Similarly to irritable temperament, there was also a
significant interaction between the anxious temperament
score and sex in predicting PWV (p = 0.023). There was
a positive association between anxious temperament
score and PWV in men (B = 0.106, SE = 0.043, p = 0.015)
which was absent in women (B = 0.047, SE = 0.036, p =
0.189) (Fig. 1c). After adjustment for age, blood glucose,
brachial systolic blood pressure and GFR-EPI, the inter-
action p-value was attenuated (p = 0.046), however the
strength of the association remained similar in men (in
men B = 0.088, SE = 0.036, p = 0.017 and in women B =
0.021, SE = 0.030, p = 0.484). The interaction became
non-significant (p = 0.135) after further adjustment for
BDI and HAMA-A scores and the regular use of al-
prazolam (in men B = 0.070, SE = 0.039, p = 0.075 and in
women B = -0.017, SE = 0.037, p = 0.656).
An interaction with borderline significance (p = 0.052)
was found between sex and hyperthymic affective tem-
perament in predicting Aix. An inverse association was
found in women (B = -0.754, SE = 0.326, p = 0.022) which
was absent in men (B = -0.305, SE = 0.370, p = 0.411)
(Fig. 1d). This interaction became weaker (p = 0.064)
after further adjustment for age, smoking, heart rate and
uric acid (in women B = -0.678, SE = 0.312, p = 0.032 and
in men B = -0.327, SE = 0.352, p = 0.325).
Table 2 Variables with significant Pearson correlations and
variables entered in the final multiple linear regression model
showing the independent predictors of brachial systolic blood
pressure, pulse wave velocity and augmentation index
Variable R p Partial Ra p
Brachial systolic blood pressure
Sex -0.155 0.048 - -
Cholesterol [mmol/l] -0.179 0.022 -0.072 0.365
DBPbrach [mmHg] 0.428 <0.001 0.474 <0.001
PPbrach [mmHg] 0.484 <0.001 0.489 <0.001
SBPcentr [mmHg] 0.591 <0.001 0.598 <0.001
DBPcetr [mmHg] 0.284 <0.001 0.329 <0.001
PPcentr [mmHg] 0.461 <0.001 0.471 <0.001
SBP amplification [mmHg] 0.281 <0.001 0.300 <0.001
PWV [m/s] 0.261 <0.001 0.265 0.001
TEMPS-A Irritable 0.171 0.030 0.151 0.056
TEMPS-A Cyclothymic 0.167 0.032 0.171 0.030
Age 0.037 0.630 - -
BDI 0.006 0.932 0.026 0.738
HAM-A 0.062 0.430 0.082 0.299
Alprazolam 0.007 0.932 0.018 0.820
Pulse wave velocity
Age [year] 0.544 <0.001 - -
Duration of hypertension [year] 0.250 <0.001 -0.019 0.808
CV disease 0.241 0.001 0.095 0.218
Blood glucose [mmol/l] 0.213 0.005 0.128 0.097
GFR-EPI [ml/min/1.73 m2] - 0.308 <0.001 -0.112 0.154
SBPbrach [mmHg] 0.260 <0.001 0.265 0.001
PPbrach [mmHg] 0.507 <0.001 0.408 <0.001
SBPcentr [mmHg] 0.410 <0.001 0.369 <0.001
PPcentr [mmHg] 0.478 <0.001 0.338 <0.001
TEMPS-A Irritable 0.156 0.040 0.173 0.025
TEMPS-A Anxious 0.157 0.039 0.156 0.043
BDI 0.164 0.031 0.104 0.176
HAM-A 0.173 0.024 0.179 0.021
Sex -0.143 0.059 - -
Alprazolam 0.121 0.111 0.078 0.308
Augmentation index
Age [year] 0.203 <0.001 - -
Sex 0.347 <0.001 - -
Current smoking [p/y] 0.159 0.038 0.175 0.023
Body height [cm] 0.247 0.001 -0.021 0.791
Heart rate [1/min] -0.195 0.013 -0.151 0.058
Uric acid [μmol/l] -0.255 <0.001 -0.163 0.035
TEMPS-A Depressive 0.168 0.027 0.041 0.595
Table 2 Variables with significant Pearson correlations and
variables entered in the final multiple linear regression model
showing the independent predictors of brachial systolic blood
pressure, pulse wave velocity and augmentation index
(Continued)
TEMPS-A Hyperthymic -0.215 0.004 -0.158 0.034
BDI 0.054 0.478 -0.097 0.210
HAM-A 0.040 0.605 -0.057 0.467
Alprazolam 0.048 0.525 -0.023 0.768
aPartial R: partial correlation coefficient, corrected for age and sex. See Table 1
for the rest of abbreviations
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Discussion
To the best of our knowledge, this is the first study to
demonstrate that, in chronic hypertensive patients, cyclo-
thymic temperament score is associated with brachial sys-
tolic blood pressure while hyperthymic temperament
score is independently related to the augmentation index
after adjustment for potential confounders including se-
verity of depression and anxiety and the use of alprazolam.
Sex differences were also found in relation with brachial
systolic blood pressure and cyclothymic temperament
score, pulse wave velocity and irritable and anxious tem-
perament scores and augmentation index and hyperthy-
mic temperament score.
Previous findings support our present observations
that affective temperaments are associated with cardio-
vascular pathology. For example, patients with cyclo-
thymic, irritable and anxious temperaments were shown to
have a tendency to obesity [31]. Depressive temperament
was also found to be associated with worse metabolic
control in type-2 diabetes [32], while anxious temperament
Table 3 Predictive value of cyclothymic affective temperament scores on brachial systolic blood pressure and of hyperthymic
affective temperament scores on augmentation index in the various models. The progressive involvement of variables into models
and other significant predictors in the final models are also demonstrated
Model B Std. Error Std. Beta P Adj. R2
Brachial systolic blood pressure
Model 1 0.023
Cyclothymic temp. score 0.539 0.247 0.171 0.030
Model 2: Model 1 + Age + Sex 0.041
Cyclothymic temp. score 0.568 0.245 0.180 0.022
Model 3: Model 2 + DBPbrach 0.245
Cyclothymic temp. score 0.464 0.218 0.147 0.034
Model 4: Model 3 + Triglyceride + Cholesterol 0.275
Cyclothymic temp. score 0.431 0.214 0.137 0.045
Model 5: Model 4 + BDI + HAM-A + Alp 0.269
Cyclothymic temp. score 0.529 0.258 0.167 0.042
Age 0.177 0.076 0.181 0.021
DBPbrach 0.629 0.094 0.482 <0.001
Triglyceride -1.981 0.987 -0.141 0.047
Augmentation index
Model 1 0.045
Hyperthymic temp. score -0.733 0.255 -0.227 0.004
Model 2: Model 1 + Age + Sex 0.187
Hyperthymic temp. score -0.509 0.239 -0.158 0.034
Model 3: Model 2 + Smoking 0.209
Hyperthymic temp. score -0.562 0.237 -0.174 0.019
Model 4: Model 3 + Heart rate 0.231
Hyperthymic temp. score -0.555 0.234 -0.172 0.019
Model 5: Model 4 + Uric acid 0.243
Hyperthymic temp. score -0.523 0.232 -0.162 0.026
Model 6: Model 5 + BDI + HAM-A + Alp 0.244
Hyperthymic temp. score -0.612 0.243 -0.189 0.013
Age 0.297 0.087 0.258 0.001
Sex 7.445 2.189 0.264 0.001
Smoking 6.159 2.610 0.176 0.020
Heart rate -0.209 0.098 -0.152 0.035
Std. Error standard error, Std. Beta Standardized Beta, Adj. R2 adjusted R2, Cyclothymic temp. score cyclothymic affective temperament score, DBPbrach brachial
diastolic blood pressure, BDI Beck Depression Inventory, HAM-A Hamilton Anxiety Scale, Alp patients regularly using alprazolam, Hyperthymic temp. score
Hyperthymic affective temperament score
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was associated with an increased likelihood for the pres-
ence of prediabetic condition [33]. Our result with regard
to cyclothymic temperament is in line with our previous
findings in which dominant cyclothymic temperament
demonstrated a significant association with the presence
of hypertension [23] and with acute coronary events in a
hypertensive patient population [24].
An increasing cyclothymic temperament score was
found herein to be associated with a higher brachial
systolic blood pressure. This temperament shows a
central dimension that includes rapid fluctuations in
mood and emotional instability. Such alterations can
span from lethargy to eutonia, from pessimistic brood-
ing to optimistic, from hypersomnia to decreased need
for sleep or from introverted self-absorption to unin-
hibited people-seeking [18]. In contrast, hyperthymic
temperament, which was associated in our study with
better wave reflection, can be described as a tempera-
ment that displays extroversion, emotional intensity, a
high level of life-energy and little need for sleep. Sub-
jects with hyperthymic temperament are cheerful, over-
optimistic, overconfident as well as over-talkative and
vigorous [18]. While the hyperthymic temperament is
associated with better quality of life (QOL), the cyclothy-
mic temperament is conversely associated with worse
QOL [18]. Moreover, people with hyperthymic tempera-
ment can better cope with somatic problems [34], while
cyclothymic disposition is related to a high somatic risk
[35]. Based on these results, we hypothesize that there is a
likely differential impact of these two temperaments on
vascular pathology, although prospective studies are re-
quired to confirm this hypothesis.
There are existing data in the literature regarding the as-
sociation between personality traits and arterial stiffening.
In a study by Midei and Matthews, higher trait anxiety
and hostility were associated with a higher PWV [36]. In
the Baltimore Longitudinal study of Aging, middle-aged
adults with suppressed anger had elevated carotid arterial
stiffness [37]. In keeping with these studies, irritable and
anxious affective temperament scores were found herein
to be covariates of PWV after adjustment for age, sex,
brachial systolic blood pressure, blood glucose, GFR-
EPI and duration of hypertension. However, these
associations became non-significant after further ad-
justment with severity of depression and anxiety and
the use of alprazolam. Given that arterial stiffness is
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Fig. 1 The interaction between sex and different affective temperaments in the prediction of the studied variables. a cyclothymic temperament
score and brachial systolic blood pressure; b irritable temperament score and pulse wave velocity; c anxious temperament score and pulse wave
velocity; d hyperthymic temperament score and augmentation index. Error bars represent ± 1 standard errors
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associated with depression and anxiety [38, 39], we can
hypothesize that, similarly to the relationship between
life stress and arterial stiffness [40], the association
between anxious and irritable affective temperaments
and PWV is partly mediated by severity of depressive
and anxiety symptoms.
Augmentation index is an accepted parameter of pulse
wave analysis. Aix is associated with age, sex, body height,
smoking and heart rate [41, 42], associations which were
also reproduced in the present study. Aix is furthermore
reported to be a predictor of mortality in various patho-
logical conditions, such as end-stage renal disease [43] or
coronary artery disease [44], and its predictive value was
also confirmed by a meta-analysis [45]. In the study of
Seldenrijk et al., anxiety-related symptoms were found to
be associated with Aix [39]. Our present results indicate
that hyperthymic affective temperament score is an inde-
pendent covariable of Aix with higher scores being associ-
ated with better wave reflection and thus a preserved
elasticity of the arteries. This suggests a protective role of
hyperthymic temperament on cardiovascular pathology
and emphasizes the potential of further evaluation of
affective temperaments with wave reflection parameters.
Significant interactions were also found in the present
study between sex and cyclothymic temperament score
in predicting brachial systolic blood pressure, between
sex and irritable temperament as well as between sex
and anxious temperament scores in predicting PWV,
while the interaction between sex and hyperthymic tem-
perament score in predicting Aix had borderline signifi-
cance. These findings are consistent with the study of
Williams et al., where trait anger was associated with
elevated arterial stiffness in men, while in women the
association was marginally significant [46]. These results
suggest that, similarly to the presence of sex differences
in scoring in different affective temperament directions
[16], sex differences are also present in the associations
between affective temperament scores and brachial
systolic blood pressure and arterial stiffness parame-
ters. Additional studies are likely needed to specify
these observed sex differences, including taking into
consideration menopausal status or the use of hormone
replacement therapy.
The pathophysiological background of our findings is
complex and remains to be clarified. Subjects in states
of anger or hostility show elevated levels of inflamma-
tion [47, 48] and those with anxiety show reduced auto-
nomic nervous system function [49]. The involvement
of neurotrophic molecules should also be considered since
we recently demonstrated decreased serum brain-derived
neurotrophic factor levels in chronic hypertensive patients
with dominant cyclothymic, depressive, anxious or irrit-
able affective temperament [25]. However, this area also
requires further studies.
One of the limitations of the present analysis is the
relatively low number of chronic hypertensive patients
used to study the associations between affective temper-
aments and blood pressure or arterial stiffness parame-
ters, which limits the generalizability of our results, as
well as the number of entered confounders into regres-
sion analyses. Another main limitation stems from its
cross-sectional design which precludes causal inference.
Moreover, although our methodology used standardized
questionnaires and excluded patients with dementia, a
complete exclusion of misinterpretations or mistakes by
patients is nevertheless impossible.
Conclusions
In conclusion, the elevated blood pressure among sub-
jects with high cyclothymic temperament and the in-
creased level of arterial stiffening in subjects with low
hyperthymic scores suggest that affective temperaments
might play a role in the development of hypertension
and arterial stiffening and thus could represent potential
markers of cardiovascular risk. The discovered sex differ-
ences in numerous studied associations may be the
consequence of the known differences in affective tem-
peraments between men and women. Cumulating data
suggest that the identification of affective temperaments
in the future can improve both the psychopathological
and cardiovascular risk stratification of patients leading
to a more accurate, personalized patient management.
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